{"DataElement":{"publicId":"7055161","version":"1","preferredName":"Secondary Cause of Death  Diagnosis Original Result Reason","preferredDefinition":"The description of the secondary or contributing reason for a patient death.","longName":"DDCNTDTH","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"6421579","version":"1","preferredName":"Death Diagnosis Domain Secondary Cause of Death Death Diagnosis Original Result","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis._The second significant event which ultimately led to death._The outcome of the death diagnosis assessment as originally received or collected.","longName":"6408103v1.0:6421577v1.0","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"6408103","version":"1","preferredName":"Death Diagnosis Domain","preferredDefinition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis.","longName":"C95087","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Death Diagnosis Domain","conceptCode":"C95087","definition":"A subject domain utilized for the submission of information encompassing and representing data, vocabulary or records related to death diagnosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"73F427A1-41D5-1B4B-E053-F662850A4A5F","latestVersionIndicator":"Yes","beginDate":"2018-08-21","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-08-21","modifiedBy":"ONEDATA","dateModified":"2018-08-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6421577","version":"1","preferredName":"Secondary Cause of Death Death Diagnosis Original Result","preferredDefinition":"The second significant event which ultimately led to death.:The outcome of the death diagnosis assessment as originally received or collected.","longName":"C116142:C117546","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Secondary Cause of Death","conceptCode":"C116142","definition":"The second significant event which ultimately led to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Death Diagnosis Original Result","conceptCode":"C117546","definition":"The outcome of the death diagnosis assessment as originally received or collected.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746D83D1-29E7-4998-E053-F662850AED2A","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-28","modifiedBy":"ONEDATA","dateModified":"2018-08-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435019","version":"1","preferredName":"Conceptual Entity","preferredDefinition":"An organizational header for concepts representing mostly abstract entities.","longName":"C20181","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D8-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CDISC:Clinical Data Interchange Standards Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"746D83D1-29F8-4998-E053-F662850AED2A","latestVersionIndicator":"Yes","beginDate":"2018-08-28","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-08-28","modifiedBy":"KUMMEROA","dateModified":"2020-06-18","changeDescription":"Released. AK 2020-6-10; Created as part of the CDISC mapping task_ghd_08.27.18","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4783272","version":"1","preferredName":"Cause of Death Reason","preferredDefinition":"The circumstance or condition that results in the death of a living being._An explanation of the cause of some phenomenon or action.","longName":"COD_RSN","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Thrombosis","valueDescription":"Thrombosis","ValueMeaning":{"publicId":"4792371","version":"1","preferredName":"Thrombosis","longName":"4792371","preferredDefinition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombosis","conceptCode":"C26891","definition":"The formation of a blood clot in the lumen of a vessel or heart chamber; causes include coagulation disorders and vascular endothelial injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"13DA6467-E753-681F-E050-BB89AD4305DE","latestVersionIndicator":"Yes","beginDate":"2015-04-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"13DA6467-E76C-681F-E050-BB89AD4305DE","beginDate":"2015-04-16","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-16","modifiedBy":"ONEDATA","dateModified":"2015-04-16","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"3604289","version":"1","preferredName":"Infection","longName":"3604289","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B9D0-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"14CDA36E-1CC1-91C0-E050-BB89AD4337FA","beginDate":"2015-04-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-28","modifiedBy":"ONEDATA","dateModified":"2015-04-28","deletedIndicator":"No"},{"value":"VOD","valueDescription":"Veno-Occlusive Disease","ValueMeaning":{"publicId":"2768635","version":"1","preferredName":"Veno-Occlusive Disease","longName":"2768635","preferredDefinition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Veno-Occlusive Disease","conceptCode":"C8301","definition":"Disorder in which veins are partially or completely obstructed or the blood flow through the veins is suboptimal.--2004","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"52DDF902-A307-5647-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-07-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-52E4-5337-E050-BB89AD433CA8","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Toxicity","valueDescription":"Toxicity","ValueMeaning":{"publicId":"4615972","version":"1","preferredName":"Toxicity","longName":"4615972","preferredDefinition":"The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09172D7F-C118-E939-E050-BB89AD434D48","latestVersionIndicator":"Yes","beginDate":"2014-11-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-11-30","modifiedBy":"ONEDATA","dateModified":"2014-11-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-52EE-5337-E050-BB89AD433CA8","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Hemorrhage","valueDescription":"Hemorrhage","ValueMeaning":{"publicId":"4395748","version":"1","preferredName":"Hemorrhage","longName":"4395748","preferredDefinition":"Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D630-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-52F9-5337-E050-BB89AD433CA8","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Graft Versus Host Disease","valueDescription":"Graft Versus Host Disease","ValueMeaning":{"publicId":"2636869","version":"1","preferredName":"Graft Versus Host Disease","longName":"2636869","preferredDefinition":"An incompatibility reaction (which may be fatal) in a subject (host) of low immunological competence (deficient lymphoid tissue) who has been the recipient of immunologically competent lymphoid tissue from a donor who lacks at least one antigen possessed by the recipient host; the reaction, or disease, is the result of action of the transplanted cells against those host tissues that possess the antigen not possessed by the donor. Seen most commonly following bone marrow transplantation, acute disease is seen after 5-40 days and chronic disease weeks to months after transplantation, affecting, principally, the gastrointestinal tract, liver, and skin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Versus Host Disease","conceptCode":"C3063","definition":"A reaction, which may be fatal, in an immunocompromised subject (host) who has received an antigenically incompatible tissue transplant (graft) from an immunocompetent donor. The reaction is secondary to the activation of the transplanted cells against those host tissues that express an antigen not expressed by the donor, and is seen most commonly following bone marrow transplantation; acute disease is seen after 5-40 days, and chronic disease occurs weeks to months after transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FF979BE-A605-6817-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-05-08","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-05-08","modifiedBy":"GDEEN","dateModified":"2023-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5304-5337-E050-BB89AD433CA8","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"APL Differentiation Syndrome","valueDescription":"APL Differentiation Syndrome","ValueMeaning":{"publicId":"4770854","version":"1","preferredName":"APL Differentiation Syndrome","longName":"4770854","preferredDefinition":"A syndrome observed in patients with acute promyelocytic leukemia treated with all-trans retinoic acid. It is characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis, and renal failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"APL Differentiation Syndrome","conceptCode":"C78597","definition":"A syndrome observed in patients with acute promyelocytic leukemia treated with all-trans retinoic acid. It is characterized by weight gain, dyspnea, pleural and pericardial effusions, leukocytosis, and renal failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"12C55855-DC6F-AD11-E050-BB89AD4346D9","latestVersionIndicator":"Yes","beginDate":"2015-04-02","endDate":null,"createdBy":"WONGW","dateCreated":"2015-04-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-530E-5337-E050-BB89AD433CA8","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Accidental death","valueDescription":"Accident Death","ValueMeaning":{"publicId":"2769015","version":"1","preferredName":"Accident Death","longName":"2769015","preferredDefinition":"An unforeseen and unplanned event or circumstance frequently causing loss or injury.: The absence of life or state of being dead.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Accident","conceptCode":"C34340","definition":"An unforeseen and unplanned event or circumstance frequently causing loss or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dead","conceptCode":"C28554","definition":"The cessation of life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9B49-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5319-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Acute GVHD","valueDescription":"Acute Graft Versus Host Disease","ValueMeaning":{"publicId":"2769014","version":"1","preferredName":"Acute Graft Versus Host Disease","longName":"2769014","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Graft Versus Host Disease","conceptCode":"C4980","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, usually affecting the skin, liver, and GI tract. The onset is usually within one hundred days of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9B21-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5323-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Adult Respiratory Distress Syndrome (ARDS)","valueDescription":"Adult Respiratory Distress Syndrome","ValueMeaning":{"publicId":"2769013","version":"1","preferredName":"Adult Respiratory Distress Syndrome","longName":"2769013","preferredDefinition":"fulminant pulmonary interstitial and alveolar edema resulting from diffuse infection, shock, or trauma of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acute Respiratory Distress Syndrome","conceptCode":"C3353","definition":"Progressive and life-threatening pulmonary distress in the absence of an underlying pulmonary condition, usually following major trauma or surgery. Cases of neonatal respiratory distress syndrome are not included in this definition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9AFC-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-532D-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Aspiration Pneumonia","valueDescription":"Aspiration Pneumonia","ValueMeaning":{"publicId":"3604295","version":"1","preferredName":"Aspiration Pneumonia","longName":"3604295","preferredDefinition":"Pneumonia secondary to aspiration of liquids and gastric contents into the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Aspiration Pneumonitis","conceptCode":"C34932","definition":"Inflammation of the lungs due to the inhalation of solid or liquid material.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-BB04-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5337-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Bacterial infection","valueDescription":"Bacterial Infection","ValueMeaning":{"publicId":"2769012","version":"1","preferredName":"Bacterial Infection","longName":"2769012","preferredDefinition":"infections and associated diseases by bacteria, general or unspecified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Bacterial Infection","conceptCode":"C2890","definition":"An acute infectious disorder that is caused by gram positive or gram negative bacteria; representative examples include pneumococcal, streptococcal, salmonella, and meningeal infections.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9AD7-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5342-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"BCNU IP","valueDescription":"Carmustine Interstitial Pneumonia","ValueMeaning":{"publicId":"3854252","version":"1","preferredName":"Carmustine Interstitial Pneumonia","longName":"3854252","preferredDefinition":"An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04): Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carmustine","conceptCode":"C349","definition":"An antineoplastic nitrosourea. Carmustine alkylates and cross-links DNA during all phases of the cell cycle, resulting in disruption of DNA function, cell cycle arrest, and apoptosis.  This agent also carbamoylates proteins, including DNA repair enzymes, resulting in an enhanced cytotoxic effect.  Carmustine is highly lipophilic and crosses the blood-brain barrier readily. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-08B0-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-534C-5337-E050-BB89AD433CA8","beginDate":"2013-08-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Cardiac failure","valueDescription":"Heart Failure","ValueMeaning":{"publicId":"2718360","version":"1","preferredName":"Heart Failure","longName":"2718360","preferredDefinition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements or the ability to do so only at an elevated filling pressure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Failure","conceptCode":"C50577","definition":"Inability of the heart to pump blood at an adequate rate to meet tissue metabolic requirements. Clinical symptoms of heart failure include: unusual dyspnea on light exertion, recurrent dyspnea occurring in the supine position, fluid retention or rales, jugular venous distension, pulmonary edema on physical exam, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D5D049-038F-6FD0-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-01-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5356-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Cardiopulmonary Arrest","valueDescription":"Cardiopulmonary Arrest","ValueMeaning":{"publicId":"3604293","version":"1","preferredName":"Cardiopulmonary Arrest","longName":"3604293","preferredDefinition":"Cessation of breathing and/or cardiac function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiopulmonary Arrest","conceptCode":"C50483","definition":"Cessation of breathing and/or cardiac function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-BADE-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5360-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Cardiovascular accident","valueDescription":"Cerebrovascular Accident","ValueMeaning":{"publicId":"3837932","version":"1","preferredName":"Cerebrovascular Accident","longName":"3837932","preferredDefinition":"A sudden loss of neurologic function secondary to hemorrhagic or ischemia in the brain parenchyma due to a vascular event. Infarction or hemorrhage may be demonstrated either directly by imaging,laboratory, or pathologic examination in patients with symptom duration less than 24 hours, or inferred by symptoms lasting greater than or equal to 24 hours (or fatal within 24 hours) that cannot be attributed to another cause.  Diagnostic tests include CT scan, MRI, angiography, and EEG to locate and evaluate the extent of the hemorrhagic or ischemic damage in the brain parenchyma, coagulation studies, complete blood count, comprehensive metabolic panel, and urinalysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stroke","conceptCode":"C3390","definition":"A sudden loss of neurological function secondary to hemorrhage or ischemia in the brain parenchyma due to a vascular event.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-695F-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-536B-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Cardiovascular Disorder","valueDescription":"Cardiovascular Disorder","ValueMeaning":{"publicId":"2630208","version":"1","preferredName":"Cardiovascular Disorder","longName":"2630208","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels).  Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension.  Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiovascular Disorder","conceptCode":"C2931","definition":"A non-neoplastic or neoplastic disorder affecting the heart or the vessels (arteries, veins and lymph vessels). Representative examples of non-neoplastic cardiovascular disorders are endocarditis and hypertension. Representative examples of neoplastic cardiovascular disorders are endocardial myxoma and angiosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2E8C3390-BBE2-1B34-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-04-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2007-04-20","modifiedBy":"COLBERTM","dateModified":"2023-09-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5376-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Central nervous system(CNS) failure","valueDescription":"Central Nervous System Failure","ValueMeaning":{"publicId":"2769009","version":"1","preferredName":"Central Nervous System Failure","longName":"2769009","preferredDefinition":"The main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A75-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5380-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Chronic GVHD","valueDescription":"Chronic Graft Versus Host Disease","ValueMeaning":{"publicId":"2769010","version":"1","preferredName":"Chronic Graft Versus Host Disease","longName":"2769010","preferredDefinition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Graft Versus Host Disease","conceptCode":"C4981","definition":"A syndrome of immunologically mediated tissue damage that may occur following an allogeneic transplant, and may affect multiple organs with manifestations similar to autoimmune diseases. The onset is usually within three years of transplantation or immunologic manipulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A9A-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"KUMMEROA","dateModified":"2023-10-30","changeDescription":null,"administrativeNotes":"2023.10.30 Alt VM added per ticket request CADSR0003010. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-538A-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Chronic liver disease","valueDescription":"Stigmata of Chronic Liver Disease","ValueMeaning":{"publicId":"3837931","version":"1","preferredName":"Stigmata of Chronic Liver Disease","longName":"3837931","preferredDefinition":"Signs of chronic liver disease which include jaundice, ascites, palmar erythema, spider hemangiomas, gynecomastia, and encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Stigmata of Chronic Liver Disease","conceptCode":"C82996","definition":"Signs of chronic liver disease which include jaundice, ascites, palmar erythema, spider hemangiomas, gynecomastia, and encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6932-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5394-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Chronic Obstructive Pulmonary Disease","valueDescription":"Chronic Obstructive Pulmonary Disease","ValueMeaning":{"publicId":"3385484","version":"1","preferredName":"Chronic Obstructive Pulmonary Disease","longName":"3385484","preferredDefinition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Obstructive Pulmonary Disease","conceptCode":"C3199","definition":"A chronic and progressive lung disorder characterized by the loss of elasticity of the bronchial tree and the air sacs, destruction of the air sacs wall, thickening of the bronchial wall, and mucous accumulation in the bronchial tree. The pathologic changes result in the disruption of the air flow in the bronchial airways. Signs and symptoms include shortness of breath, wheezing, productive cough, and chest tightness. The two main types of chronic obstructive pulmonary disease are chronic obstructive bronchitis and emphysema.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9A72D8B-F30F-0839-E040-BB89AD437342","latestVersionIndicator":"Yes","beginDate":"2012-02-23","endDate":null,"createdBy":"REEVESD","dateCreated":"2012-02-23","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-539E-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Congestive Heart Failure","valueDescription":"Congestive heart failure","ValueMeaning":{"publicId":"2565944","version":"1","preferredName":"Congestive heart failure","longName":"2565944","preferredDefinition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Congestive Heart Failure","conceptCode":"C3080","definition":"Failure of the heart to pump a sufficient amount of blood to meet the needs of the body tissues, resulting in tissue congestion and edema. Signs and symptoms include shortness of breath, pitting edema, enlarged tender liver, engorged neck veins, and pulmonary rales.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CEA5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-19","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-05-19","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53A8-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Coronary artery disease (atherosclerosis)","valueDescription":"Coronary Disease","ValueMeaning":{"publicId":"2760269","version":"1","preferredName":"Coronary Disease","longName":"2760269","preferredDefinition":"An imbalance between myocardial functional requirements and the capacity of the coronary vessels to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Coronary Artery Disease","conceptCode":"C26732","definition":"Narrowing of the coronary arteries due to fatty deposits inside the arterial walls. The diagnostic criteria may include documented history of any of the following: documented coronary artery stenosis greater than or equal to 50% (by cardiac catheterization or other modality of direct imaging of the coronary arteries); previous coronary artery bypass surgery (CABG); previous percutaneous coronary intervention (PCI); previous myocardial infarction. (ACC)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4FF5CBC6-3CA7-1060-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53B2-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Dementia  (including Alzheimer's disease)","valueDescription":"Dementia","ValueMeaning":{"publicId":"3165569","version":"1","preferredName":"Dementia","longName":"3165569","preferredDefinition":"An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dementia","conceptCode":"C4786","definition":"Loss of intellectual abilities interfering with an individual's social and occupational functions. Causes include Alzheimer's disease, brain injuries, brain tumors, and vascular disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"96FCF74F-C196-EAB7-E040-BB89AD437850","latestVersionIndicator":"Yes","beginDate":"2010-12-09","endDate":null,"createdBy":"LUY","dateCreated":"2010-12-09","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53BD-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Diabetes Mellitus","valueDescription":"Diabetes Mellitus","ValueMeaning":{"publicId":"3292684","version":"1","preferredName":"Diabetes Mellitus","longName":"3292684","preferredDefinition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diabetes Mellitus","conceptCode":"C2985","definition":"A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AEA65AE0-D82E-3EBD-E040-BB89AD431EBC","latestVersionIndicator":"Yes","beginDate":"2011-10-06","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-06","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53C8-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Disseminated intravascular coagulation (DIC)","valueDescription":"DIC","ValueMeaning":{"publicId":"2769008","version":"1","preferredName":"DIC","longName":"2769008","preferredDefinition":"Disseminated intravascular coagulation (DIC) is a pathological process in the body where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased the risk of hemorrhage.  There are a variety of causes of DIC, all usually causing the release of chemicals into the blood that instigates the coagulation. (from Wikipedia)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disseminated Intravascular Coagulation","conceptCode":"C2992","definition":"A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A4D-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53D2-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Failure to Thrive","valueDescription":"Failure to Thrive","ValueMeaning":{"publicId":"3854253","version":"1","preferredName":"Failure to Thrive","longName":"3854253","preferredDefinition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Failure to Thrive","conceptCode":"C107587","definition":"A clinical finding indicating less than normal growth in an infant or child, or a state of global decline in an adult.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-08D5-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53DC-5337-E050-BB89AD433CA8","beginDate":"2013-08-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Fungal infection","valueDescription":"Fungal Infection","ValueMeaning":{"publicId":"2769007","version":"1","preferredName":"Fungal Infection","longName":"2769007","preferredDefinition":"An infection caused by eukaryotic heterotrophic organisms that live as saprobes or parasites, including mushrooms, yeasts, smuts, molds, etc. They reproduce either sexually or asexually, and have life cycles that range from simple to complex. Filamentous fungi refer to those that grow as multicellular colonies (mushrooms and molds).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fungal Infection","conceptCode":"C3245","definition":"An infection caused by a fungus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A28-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53E6-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Gastrointestinal (GI) failure (not liver)","valueDescription":"Gastrointestinal Failure","ValueMeaning":{"publicId":"2769005","version":"1","preferredName":"Gastrointestinal Failure","longName":"2769005","preferredDefinition":"(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-99DE-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53F0-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Gastrointestinal hemorrhage","valueDescription":"Gastrointestinal Hemorrhage","ValueMeaning":{"publicId":"2769006","version":"1","preferredName":"Gastrointestinal Hemorrhage","longName":"2769006","preferredDefinition":"(GAS-tro-in-TES-tih-nul) GI.  Refers to the stomach and intestines.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Gastrointestinal","conceptCode":"C13359","definition":"Pertaining to the stomach and intestines.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9A03-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-53FA-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Graft rejection or failure","valueDescription":"Graft Rejection","ValueMeaning":{"publicId":"2779293","version":"1","preferredName":"Graft Rejection","longName":"2779293","preferredDefinition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Graft Failure","conceptCode":"C75570","definition":"Failure of transplanted tissue to become functional or operational, often as a result of destruction by the host's immune system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55EE40E7-CD96-5FD7-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-09-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5404-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Hemorrhage, not otherwise specified","valueDescription":"Hemorrhage Not Otherwise Specified","ValueMeaning":{"publicId":"2769002","version":"1","preferredName":"Hemorrhage Not Otherwise Specified","longName":"2769002","preferredDefinition":"Bleeding or escape of blood from a vessel.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9966-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-540E-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Hemorrhagic cystitis","valueDescription":"Hemorrhage Cystitis","ValueMeaning":{"publicId":"2769003","version":"1","preferredName":"Hemorrhage Cystitis","longName":"2769003","preferredDefinition":"Bleeding or escape of blood from a vessel.: Inflammation of the urinary bladder. (Dorland, 27th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cystitis","conceptCode":"C26738","definition":"Inflammation of the urinary bladder.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-998E-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5418-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Hepatitis","valueDescription":"Hepatitis","ValueMeaning":{"publicId":"3257061","version":"1","preferredName":"Hepatitis","longName":"3257061","preferredDefinition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hepatitis","conceptCode":"C3095","definition":"Inflammation of the liver; usually from a viral infection, but sometimes from toxic agents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8AA35B8-AD6E-E3A8-E040-BB89AD43122A","latestVersionIndicator":"Yes","beginDate":"2011-07-22","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2011-07-22","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5422-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Herpes","valueDescription":"Herpes","ValueMeaning":{"publicId":"3837928","version":"1","preferredName":"Herpes","longName":"3837928","preferredDefinition":"Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Herpes","conceptCode":"C50583","definition":"Any inflammatory skin disease caused by a herpesvirus and characterized by the formation of small vesicles in clusters.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-688F-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-542D-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"HIV/AIDS","valueDescription":"Human Immunodeficiency Virus And/Or Acquired Immunodeficiency Syndrome","ValueMeaning":{"publicId":"3838716","version":"1","preferredName":"Human Immunodeficiency Virus And/Or Acquired Immunodeficiency Syndrome","longName":"3838716","preferredDefinition":"Human immunodeficiency virus. Species of LENTIVIRUS, subgenus primate lentiviruses (LENTIVIRUSES, PRIMATE), formerly designated T-cell lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). It is acknowledged to be the agent responsible for the acute infectious manifestations, neurologic disorders, and immunologic abnormalities linked to the ACQUIRED IMMUNODEFICIENCY SYNDROME.: Used to indicate that either or both of two items or options may be valid.: A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Human Immunodeficiency Virus","conceptCode":"C14219","definition":"The virus isolated and recognized as the etiologic agent of AIDS. HIV-1 is classified as a lentivirus, a subtype of retroviruses.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And/Or","conceptCode":"C48928","definition":"Used to indicate that either or both of two items or options may be valid.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E34BBF24-FDA3-768F-E040-BB89AD4334A3","latestVersionIndicator":"Yes","beginDate":"2013-08-06","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-06","modifiedBy":"ONEDATA","dateModified":"2013-08-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5437-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Infection, organism not identified","valueDescription":"Infection Organism Not Identified","ValueMeaning":{"publicId":"2768993","version":"1","preferredName":"Infection Organism Not Identified","longName":"2768993","preferredDefinition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.: A living thing, such as an animal, a plant, a bacterium, or a fungus.: The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Organism","conceptCode":"C14250","definition":"A living entity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Identified","conceptCode":"C48661","definition":"The finding is not present, but a value of 'none' cannot be unequivocally established absence in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-984D-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5441-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Influenza","valueDescription":"Influenza","ValueMeaning":{"publicId":"3604288","version":"1","preferredName":"Influenza","longName":"3604288","preferredDefinition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Influenza","conceptCode":"C53482","definition":"An acute viral infection of the respiratory tract, occurring in isolated cases, in epidemics, or in pandemics; it is caused by serologically different strains of viruses (influenzaviruses) designated A, B, and C, has a 3-day incubation period, and usually lasts for 3 to 10 days. It is marked by inflammation of the nasal mucosa, pharynx, and conjunctiva; headache; myalgia; often fever, chills, and prostration; and occasionally involvement of the myocardium or central nervous system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B9AD-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-544B-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Interstitial Pneumonia (IP) NOS","valueDescription":"Not Otherwise Specified Interstitial Pneumonia","ValueMeaning":{"publicId":"3854251","version":"1","preferredName":"Not Otherwise Specified Interstitial Pneumonia","longName":"3854251","preferredDefinition":"Not characterized in any other way.: Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-088A-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5456-5337-E050-BB89AD433CA8","beginDate":"2013-08-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Intracranial hemorrhage","valueDescription":"Intracranial Hemorrhage","ValueMeaning":{"publicId":"2768998","version":"1","preferredName":"Intracranial Hemorrhage","longName":"2768998","preferredDefinition":"Bleeding within the cranium.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intracranial Hemorrhage","conceptCode":"C50438","definition":"Bleeding within the cranium.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-98EF-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5460-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"IPS, idiopathic","valueDescription":"Idiopathic Pneumonia Syndrome Idiopathic","ValueMeaning":{"publicId":"2774525","version":"1","preferredName":"Idiopathic Pneumonia Syndrome Idiopathic","longName":"2774525","preferredDefinition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.: Describes a disease of unknown cause.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Idiopathic","conceptCode":"C28242","definition":"Describes a disease of unknown cause.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-2252-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-546A-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"IPS, viral, cytomegalovirus(CMV)","valueDescription":"Idiopathic Pneumonia Syndrome Viral Cytomegalovirus","ValueMeaning":{"publicId":"2768977","version":"1","preferredName":"Idiopathic Pneumonia Syndrome Viral Cytomegalovirus","longName":"2768977","preferredDefinition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.: Having to do with a virus.: A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cytomegalovirus","conceptCode":"C14196","definition":"A genus of the family herpesviridae, subfamily betaherpesvirinae, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9603-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5474-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"IPS, viral, other","valueDescription":"Idiopathic Pneumonia Syndrome Viral Other","ValueMeaning":{"publicId":"2768975","version":"1","preferredName":"Idiopathic Pneumonia Syndrome Viral Other","longName":"2768975","preferredDefinition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.: Having to do with a virus.: Not otherwise specified.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Idiopathic Pneumonia Syndrome","conceptCode":"C62590","definition":"An inflammatory lung disease characterized by diffuse interstitial pneumonitis and alveolitis leading to interstitial fibrosis in the absence of an identifiable infectious agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Viral","conceptCode":"C27985","definition":"Having to do with a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-95B5-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-547E-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Liver failure (not VOD)","valueDescription":"Liver Failure","ValueMeaning":{"publicId":"2768996","version":"1","preferredName":"Liver Failure","longName":"2768996","preferredDefinition":"A large organ located in the upper abdomen. The liver cleanses the blood and aids in digestion by secreting bile.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver","conceptCode":"C12392","definition":"A triangular-shaped organ located under the diaphragm in the right hypochondrium. It is the largest internal organ of the body, weighting up to 2 kg. Metabolism and bile secretion are its main functions. It is composed of cells which have the ability to regenerate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-98C7-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5488-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Multiple Organ Failure","valueDescription":"Multiple Organ Failure","ValueMeaning":{"publicId":"2768995","version":"1","preferredName":"Multiple Organ Failure","longName":"2768995","preferredDefinition":"A progressive condition usually characterized by combined failure of the lungs, liver, kidney, and clotting mechanisms.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Multiple Organ Failure","conceptCode":"C75568","definition":"Complete impairment of two or more organs or organ systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-989F-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5492-5337-E050-BB89AD433CA8","beginDate":"2008-09-02","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Myocardial infarction","valueDescription":"Myocardial infarction","ValueMeaning":{"publicId":"2569449","version":"1","preferredName":"Myocardial infarction","longName":"2569449","preferredDefinition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area. (Dorland, 27th ed)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myocardial Infarction","conceptCode":"C27996","definition":"Gross necrosis of the myocardium, as a result of interruption of the blood supply to the area, as in coronary thrombosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DC56-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-04-26","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-04-26","modifiedBy":"ALAIS","dateModified":"2006-08-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-549C-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Natural causes","valueDescription":"Natural Cause of Death","ValueMeaning":{"publicId":"3837948","version":"1","preferredName":"Natural Cause of Death","longName":"3837948","preferredDefinition":"A description for something that exists in or is produced by nature, and is not artificial or man-made.: The circumstance or condition that results in the death of a living being.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Natural","conceptCode":"C85060","definition":"A description for something that exists in or is produced by nature, and is not artificial or man-made.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6B0E-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54A6-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Non-protocol cancer therapy","valueDescription":"Non-Protocol Cancer Treatment","ValueMeaning":{"publicId":"3837947","version":"1","preferredName":"Non-Protocol Cancer Treatment","longName":"3837947","preferredDefinition":"Treatment not specified in a protocol.: Any intervention for management of a malignant neoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Protocol","conceptCode":"C25590","definition":"Treatment not specified in a protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Cancer Therapeutic Procedure","conceptCode":"C16212","definition":"Any intervention for management of a malignant neoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6AE8-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54B0-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Organ failure, not otherwise specified","valueDescription":"Organ Failure Not Otherwise Specified","ValueMeaning":{"publicId":"2768994","version":"1","preferredName":"Organ Failure Not Otherwise Specified","longName":"2768994","preferredDefinition":"A part of the body that performs a specific function.  For example, the heart is an organ.: loss of ability to function normally.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Organ","conceptCode":"C13018","definition":"A unique macroscopic (gross) anatomic structure that performs specific functions. It is composed of various tissues.  An organ is part of an anatomic system or a body region. Representative examples include the heart, lung, liver, spleen, and uterus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9876-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54BA-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Other cause","valueDescription":"Other Reason","ValueMeaning":{"publicId":"2762648","version":"1","preferredName":"Other Reason","longName":"2762648","preferredDefinition":"Not otherwise specified.: An explanation of the cause of some phenomenon or action.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"510F7405-014B-02E3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-07-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54C4-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Parkinson's Disease","valueDescription":"Parkinson's Disease","ValueMeaning":{"publicId":"3604284","version":"1","preferredName":"Parkinson's Disease","longName":"3604284","preferredDefinition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Parkinson Disease","conceptCode":"C26845","definition":"A progressive degenerative disorder of the central nervous system characterized by loss of dopamine producing neurons in the substantia nigra and the presence of Lewy bodies in the substantia nigra and locus coeruleus. Signs and symptoms include tremor which is most pronounced during rest, muscle rigidity, slowing of the voluntary movements, a tendency to fall back, and a mask-like facial expression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CB3FE6FA-B91F-21CD-E040-BB89AD436BD1","latestVersionIndicator":"Yes","beginDate":"2012-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2012-10-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54CF-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Persistence or recurrence of underlying disease","valueDescription":"Persistent Disease Or Recurrent Disease","ValueMeaning":{"publicId":"3837946","version":"1","preferredName":"Persistent Disease Or Recurrent Disease","longName":"3837946","preferredDefinition":"A disease that does not go to remission despite treatment.: An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.: The return of a disease after a period of remission.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Persistent Disease","conceptCode":"C90169","definition":"A disease that does not go to remission despite treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Or","conceptCode":"C37998","definition":"An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6AB1-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54DA-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Pneumonia NOS","valueDescription":"Not Otherwise Specified Pneumonia","ValueMeaning":{"publicId":"3837945","version":"1","preferredName":"Not Otherwise Specified Pneumonia","longName":"3837945","preferredDefinition":"Not characterized in any other way.: Inflammation of the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pneumonia","conceptCode":"C3333","definition":"An acute, acute and chronic, or chronic inflammation focally or diffusely affecting the lung parenchyma, due to infections (viruses, fungi, mycoplasma, or bacteria), treatment (e.g. radiation), or exposure (inhalation) to chemicals. Symptoms include cough, shortness of breath, fevers, chills, chest pain, headache, sweating, and weakness.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6A8A-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54E4-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Prior malignancy","valueDescription":"Prior Malignant Neoplasm","ValueMeaning":{"publicId":"2774527","version":"1","preferredName":"Prior Malignant Neoplasm","longName":"2774527","preferredDefinition":"Earlier in time or order.: A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"545BF7ED-22A1-164E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"NYCHM","dateCreated":"2008-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54EE-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Protozoal infection","valueDescription":"Protozoal Infection","ValueMeaning":{"publicId":"2573841","version":"1","preferredName":"Protozoal Infection","longName":"2573841","preferredDefinition":"Infections with unicellular organisms of the subkingdom PROTOZOA.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Protozoal Infection","conceptCode":"C34953","definition":"An infection that is caused by protozoans.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-ED7E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-03-28","modifiedBy":"COOPERM","dateModified":"2008-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-54F8-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Pulmonary Embolism","valueDescription":"Pulmonary Embolism","ValueMeaning":{"publicId":"2770974","version":"1","preferredName":"Pulmonary Embolism","longName":"2770974","preferredDefinition":"The closure of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary Embolism","conceptCode":"C50713","definition":"The obstruction of the pulmonary artery or one of its branches by an embolus, sometimes associated with infarction of the lung.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53F2DD1F-DD5A-0AF3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-08-08","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5502-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Pulmonary failure","valueDescription":"Pulmonary Failure","ValueMeaning":{"publicId":"2768984","version":"1","preferredName":"Pulmonary Failure","longName":"2768984","preferredDefinition":"Relating to the lungs.: loss of ability to function normally.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Failure","conceptCode":"C25745","definition":"A lack of occurrence or performance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-96DC-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-550D-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Pulmonary hemorrhage","valueDescription":"Pulmonary Hemorrhage","ValueMeaning":{"publicId":"2750111","version":"1","preferredName":"Pulmonary Hemorrhage","longName":"2750111","preferredDefinition":"Relating to the lungs.: Bleeding or escape of blood from a vessel.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hemorrhage","conceptCode":"C26791","definition":"The flow of blood from a ruptured blood vessel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4D5CE735-FC29-136E-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-05-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5517-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Radiation IP","valueDescription":"Radiation Therapy Interstitial Pneumonia","ValueMeaning":{"publicId":"3854250","version":"1","preferredName":"Radiation Therapy Interstitial Pneumonia","longName":"3854250","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: Inflammation of interstitial lung tissue, usually associated with infection.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Interstitial Pneumonia","conceptCode":"C27006","definition":"Inflammation of interstitial lung tissue, usually associated with infection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E3D82D79-0864-7EED-E040-BB89AD433B9E","latestVersionIndicator":"Yes","beginDate":"2013-08-13","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-13","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5521-5337-E050-BB89AD433CA8","beginDate":"2013-08-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Recurrence/persistence/progression of disease reported for first HSCT","valueDescription":"Recurrence Persistent PD","ValueMeaning":{"publicId":"2768983","version":"1","preferredName":"Recurrence Persistent PD","longName":"2768983","preferredDefinition":"To come back or to return.: Retained; never-ceasing.: Cancer that is increasing in scope or severity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrence","conceptCode":"C3352","definition":"Happening again (especially at regular intervals).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Persistent","conceptCode":"C43623","definition":"Retained; never-ceasing.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Progressive Disease","conceptCode":"C35571","definition":"A clinical, pathologic, and/or molecular finding indicating that the course of a disease is worsening in terms of extent or severity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-96B4-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-552B-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Renal failure","valueDescription":"Renal Failure","ValueMeaning":{"publicId":"2768982","version":"1","preferredName":"Renal Failure","longName":"2768982","preferredDefinition":"Acute or chronic condition, characterized by the inability of the kidneys to adequately filter the blood substances, resulting in uremia and electrolyte imbalances.  Acute renal failure is usually associated with oliguria or anuria, hyperkalemia, and pulmonary edema.  Chronic renal failure is irreversible and requires hemodialysis.--2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal Failure","conceptCode":"C4376","definition":"An acute or chronic condition that is characterized by the inability of the kidneys to adequately filter the blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-968B-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"COLBERTM","dateModified":"2023-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5535-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Respiratory failure","valueDescription":"Respiratory Failure","ValueMeaning":{"publicId":"2946095","version":"1","preferredName":"Respiratory Failure","longName":"2946095","preferredDefinition":"Impaired gas exchange by the respiratory system resulting in hypoxemia and decreased oxygenation of the tissues that may be associated with increased arterial levels of carbon dioxide. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Respiratory Failure","conceptCode":"C26872","definition":"The significant impairment of gas exchange within the lungs resulting in hypoxia, hypercarbia, or both, to the extent that organ tissue perfusion is severely compromised. Causes include chronic obstructive pulmonary disease, asthma, emphysema, acute respiratory distress syndrome, pneumonia, pulmonary edema, pneumothorax, and congestive heart failure. Treatment requires intubation and mechanical ventilation until the time the lungs recover sufficient function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746AE5AE-679E-370C-E040-BB89AD4351E3","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-553F-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Sepsis","valueDescription":"Septicemia","ValueMeaning":{"publicId":"2946181","version":"1","preferredName":"Septicemia","longName":"2946181","preferredDefinition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Septicemia","conceptCode":"C3364","definition":"The presence of pathogenic microorganisms in the blood stream causing a rapidly progressing systemic reaction that may lead to shock. Symptoms include fever, chills, tachycardia, and increased respiratory rate. It is a medical emergency that requires urgent medical attention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746BFDBA-4A29-B144-E040-BB89AD4341DF","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-554A-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Suicide","valueDescription":"Suicide","ValueMeaning":{"publicId":"2572283","version":"1","preferredName":"Suicide","longName":"2572283","preferredDefinition":"The act of ending one's own life.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Suicide","conceptCode":"C3394","definition":"The act of ending one's own life.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E768-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-01","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-01","modifiedBy":"COOPERM","dateModified":"2008-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5555-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Thromboembolic","valueDescription":"Thromboembolism","ValueMeaning":{"publicId":"2768980","version":"1","preferredName":"Thromboembolism","longName":"2768980","preferredDefinition":"Obstruction of a vessel by a blood clot that has been transported from a distant site by the blood stream.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thromboembolism","conceptCode":"C28195","definition":"Occlusion of the lumen of a vessel by a thrombus that has migrated from a distal site via the blood stream.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-9653-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-555F-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Thrombotic thrombocytopenic purpura (HUS/TTP)","valueDescription":"Thrombocytopenic Purpura","ValueMeaning":{"publicId":"2769001","version":"1","preferredName":"Thrombocytopenic Purpura","longName":"2769001","preferredDefinition":"Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Thrombocytopenic Purpura","conceptCode":"C26870","definition":"Purpura associated with a reduction in circulating blood platelets which can result from a variety of factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-993E-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5569-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Unclassified infection / Infection NOS","valueDescription":"Not Otherwise Specified Unclassified Infection","ValueMeaning":{"publicId":"3837944","version":"1","preferredName":"Not Otherwise Specified Unclassified Infection","longName":"3837944","preferredDefinition":"Not characterized in any other way.: Not arranged or included in any specific grouping.: A disorder resulting from the presence and activity of a microbial, viral, or parasitic agent. It can be transmitted by direct or indirect contact.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Unclassified","conceptCode":"C64486","definition":"Not arranged or included in any specific grouping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Infectious Disorder","conceptCode":"C26726","definition":"A disorder resulting from the presence and activity of a microbial, viral, fungal, or parasitic agent. It can be transmitted by direct or indirect contact.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E338EA85-6A46-9EBB-E040-BB89AD435D80","latestVersionIndicator":"Yes","beginDate":"2013-08-05","endDate":null,"createdBy":"ZHANGW","dateCreated":"2013-08-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5573-5337-E050-BB89AD433CA8","beginDate":"2013-08-05","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Vascular, not otherwise specified","valueDescription":"Vascular Not Otherwise Specified","ValueMeaning":{"publicId":"2768978","version":"1","preferredName":"Vascular Not Otherwise Specified","longName":"2768978","preferredDefinition":"Relating to or containing blood vessels.: Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Vascular","conceptCode":"C13311","definition":"Relating to or containing blood vessels.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-962B-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-557D-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Veno-occlusive disease (VOD) / sinusodial obstruction syndrome (SOS)","valueDescription":"Hepatic Veno-Occlusive Disease","ValueMeaning":{"publicId":"2793925","version":"1","preferredName":"Hepatic Veno-Occlusive Disease","longName":"2793925","preferredDefinition":"Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594FA4A3-3296-6DA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-15","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5587-5337-E050-BB89AD433CA8","beginDate":"2008-08-13","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Viral infection","valueDescription":"Viral Infection","ValueMeaning":{"publicId":"2768976","version":"1","preferredName":"Viral Infection","longName":"2768976","preferredDefinition":"A general term for diseases produced by viruses.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Viral Infection","conceptCode":"C3439","definition":"Any disease caused by a virus.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"53198A5F-95DA-1FF8-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"COOPERM","dateCreated":"2008-07-28","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"132D4785-5591-5337-E050-BB89AD433CA8","beginDate":"2008-07-28","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","deletedIndicator":"No"},{"value":"Drug Related","valueDescription":"Drug Toxicity","ValueMeaning":{"publicId":"2760851","version":"1","preferredName":"Drug Toxicity","longName":"2760851","preferredDefinition":"An adverse effect of a drug used therapeutically or diagnostically.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Toxicity","conceptCode":"C27955","definition":"An adverse effect of a drug used therapeutically or diagnostically.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"506AAF2A-F05C-1D80-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"328FD31A-B6EC-D3F9-E050-BB89AD433ED9","beginDate":"2016-05-11","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-11","modifiedBy":"ONEDATA","dateModified":"2016-05-11","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2565695","version":"1","preferredName":"Unknown","longName":"2565695","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CDAC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-02-26","endDate":null,"createdBy":"MEDVEDOH","dateCreated":"2003-02-26","modifiedBy":"MMADDINENI","dateModified":"2024-02-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3209282D-1024-023E-E050-BB89AD437EA1","beginDate":"2016-05-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-04","modifiedBy":"ONEDATA","dateModified":"2016-05-04","deletedIndicator":"No"},{"value":"Adverse Event","valueDescription":"Adverse Event","ValueMeaning":{"publicId":"5207091","version":"1","preferredName":"Adverse Event","longName":"5207091","preferredDefinition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adverse Event","conceptCode":"C41331","definition":"Any unfavorable or unintended disease, sign, or symptom (including an abnormal laboratory finding) that is temporally associated with the use of a medical treatment or procedure, and that may or may not be considered related to the medical treatment or procedure. Such events can be related to the intervention, dose, route of administration, patient, or caused by an interaction with another drug(s) or procedure(s).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2F472F56-9C7D-2892-E050-BB89AD437FF9","latestVersionIndicator":"Yes","beginDate":"2016-03-30","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-03-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3209282D-1080-023E-E050-BB89AD437EA1","beginDate":"2016-05-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2016-05-04","modifiedBy":"ONEDATA","dateModified":"2016-05-04","deletedIndicator":"No"},{"value":"Cardiac Disease","valueDescription":null,"ValueMeaning":{"publicId":"3181118","version":"1","preferredName":"Heart Disorder","longName":"3181118","preferredDefinition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Heart Disorder","conceptCode":"C3079","definition":"A non-neoplastic or neoplastic disorder that affects the heart and/or the pericardium. Representative examples include endocarditis, pericarditis, atrial myxoma, cardiac myeloid sarcoma, and pericardial malignant mesothelioma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"991CC1A7-5429-0D9B-E040-BB89AD4320EF","latestVersionIndicator":"Yes","beginDate":"2011-01-05","endDate":null,"createdBy":"LUY","dateCreated":"2011-01-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F708CAEC-E098-7640-E053-731AD00A3DCF","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","deletedIndicator":"No"},{"value":"Immunotherapy-Related","valueDescription":null,"ValueMeaning":{"publicId":"13204084","version":"1","preferredName":"Immunotherapy-Related","longName":"13204084v1.00","preferredDefinition":"An observation that a situation is related to immunotherapy received.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunotherapy-Related","conceptCode":"C168874","definition":"An observation that a situation is related to immunotherapy received.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F708CAEC-E096-7640-E053-731AD00A3DCF","latestVersionIndicator":"Yes","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F708CAEC-E099-7640-E053-731AD00A3DCF","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","deletedIndicator":"No"},{"value":"Pulmonary Disease","valueDescription":null,"ValueMeaning":{"publicId":"5054452","version":"1","preferredName":"Lung Disorder","longName":"5054452","preferredDefinition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung Disorder","conceptCode":"C3198","definition":"A non-neoplastic or neoplastic disorder affecting the lung. Representative examples of non-neoplastic disorders include chronic obstructive pulmonary disease and pneumonia. Representative examples of neoplastic disorders include benign processes (e.g., respiratory papilloma) and malignant processes (e.g., lung carcinoma and metastatic cancer to the lung).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"25628B4B-6B19-594C-E050-BB89AD430F0C","latestVersionIndicator":"Yes","beginDate":"2015-11-25","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2015-11-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F708CAEC-E09A-7640-E053-731AD00A3DCF","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","deletedIndicator":"No"},{"value":"Surgical Complication","valueDescription":null,"ValueMeaning":{"publicId":"13204085","version":"1","preferredName":"Surgical Complication","longName":"13204085v1.00","preferredDefinition":"A disease or disorder that occurs during, soon after or as a result of a surgical procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Surgical Complication","conceptCode":"C164157","definition":"A disease or disorder that occurs during, soon after or as a result of a surgical procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F708CAEC-E097-7640-E053-731AD00A3DCF","latestVersionIndicator":"Yes","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F708CAEC-E09B-7640-E053-731AD00A3DCF","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F708CAEC-E09C-7640-E053-731AD00A3DCF","beginDate":"2023-03-16","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-03-16","modifiedBy":"COLBERTM","dateModified":"2023-03-16","deletedIndicator":"No"},{"value":"Infection, NOS","valueDescription":null,"ValueMeaning":{"publicId":"13347071","version":"1","preferredName":"Infection Not Otherwise Specified","longName":"13347071v1.00","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce._Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9222469-88F7-3BD4-E053-731AD00AF585","latestVersionIndicator":"Yes","beginDate":"2023-04-12","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-12","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9222469-88F8-3BD4-E053-731AD00AF585","beginDate":"2023-04-12","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-12","modifiedBy":"JKNABLE","dateModified":"2023-04-12","deletedIndicator":"No"},{"value":"Sinusoidal Obstruction Syndrome","valueDescription":null,"ValueMeaning":{"publicId":"2793925","version":"1","preferredName":"Hepatic Veno-Occlusive Disease","longName":"2793925","preferredDefinition":"Blockage of the small- or medium-sized hepatic veins due to nonthrombotic subendothelial edema which may progress to fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sinusoidal Obstruction Syndrome","conceptCode":"C26793","definition":"A disorder characterized by inflammation and damage of the hepatic sinusoidal endothelial cells of the hepatic venules that leads to venular occlusion and hepatocellular necrosis. It is most often a conditioning-related toxicity that results as a complication of hematopoietic stem cell transplantation (HSCT). It has also been described in populations of individuals who have ingested pyrrolizidine plant alkaloids. The clinical signs and symptoms include hyperbilirubinemia, hepatomegaly, and fluid retention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"594FA4A3-3296-6DA9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"CZECHS","dateCreated":"2008-10-15","modifiedBy":"COLBERTM","dateModified":"2023-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F9222469-88F9-3BD4-E053-731AD00AF585","beginDate":"2023-04-12","endDate":null,"createdBy":"JKNABLE","dateCreated":"2023-04-12","modifiedBy":"JKNABLE","dateModified":"2023-04-12","deletedIndicator":"No"},{"value":"Unacceptable Toxicity","valueDescription":null,"ValueMeaning":{"publicId":"13571067","version":"1","preferredName":"Unacceptable Toxicity","longName":"13571067v1.00","preferredDefinition":"Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unacceptable Toxicity","conceptCode":"C199267","definition":"Therapy-related toxicity leading to multiple treatment dose reductions or delays, early treatment stoppage, unplanned hospital admission, or death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FBBC76EA-9547-1E70-E053-731AD00A988E","latestVersionIndicator":"Yes","beginDate":"2023-05-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-15","modifiedBy":"COLBERTM","dateModified":"2023-05-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FBBC76EA-9548-1E70-E053-731AD00A988E","beginDate":"2023-05-15","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-05-15","modifiedBy":"COLBERTM","dateModified":"2023-05-15","deletedIndicator":"No"},{"value":"Cancer Related","valueDescription":null,"ValueMeaning":{"publicId":"14473325","version":"1","preferredName":"Cancer-Related Death","longName":"14473325v1.00","preferredDefinition":"A death attributed to the progression of a cancer-related pathologic condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cancer-Related Death","conceptCode":"C156427","definition":"A death attributed to the progression of a cancer-related pathologic condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"051989A7-2E96-7F36-E063-731AD00A2797","latestVersionIndicator":"Yes","beginDate":"2023-09-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-11","modifiedBy":"COLBERTM","dateModified":"2023-09-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"051989A7-2E97-7F36-E063-731AD00A2797","beginDate":"2023-09-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-11","modifiedBy":"COLBERTM","dateModified":"2023-09-11","deletedIndicator":"No"},{"value":"Not Cancer Related","valueDescription":null,"ValueMeaning":{"publicId":"7642107","version":"1","preferredName":"Non-Cancer Related Death","longName":"7642107","preferredDefinition":"A death attributed to any cause other than the progression of a cancer-related pathologic condition.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Cancer Related Death","conceptCode":"C156428","definition":"A death attributed to any cause other than the progression of a cancer-related pathologic condition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0BC9E02-D764-7DB2-E053-4EBD850A3980","latestVersionIndicator":"Yes","beginDate":"2021-04-24","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-24","modifiedBy":"ONEDATA","dateModified":"2021-04-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"051989A7-2E98-7F36-E063-731AD00A2797","beginDate":"2023-09-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-11","modifiedBy":"COLBERTM","dateModified":"2023-09-11","deletedIndicator":"No"},{"value":"Spinal Muscular Atrophy","valueDescription":null,"ValueMeaning":{"publicId":"3211451","version":"1","preferredName":"Spinal Muscular Atrophy","longName":"3211451","preferredDefinition":"An inherited disorder characterized by degeneration of the spinal cord and the cerebellum. Symptoms may appear at any age and include progressive loss of coordination of gait, hands, speech, and eye movements.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Spinal Muscular Atrophy","conceptCode":"C85075","definition":"An inherited disorder characterized by degeneration of the spinal cord and the cerebellum. Symptoms may appear at any age and include progressive loss of coordination of gait, hands, speech, and eye movements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-FFB7-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"051989A7-2E99-7F36-E063-731AD00A2797","beginDate":"2023-09-11","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-11","modifiedBy":"COLBERTM","dateModified":"2023-09-11","deletedIndicator":"No"},{"value":"Renal Disorder, NOS","valueDescription":null,"ValueMeaning":{"publicId":"2975595","version":"1","preferredName":"Renal Disorder","longName":"2975595","preferredDefinition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Disorder","conceptCode":"C3149","definition":"A neoplastic or non-neoplastic condition affecting the kidney. Representative examples of non-neoplastic conditions include glomerulonephritis and nephrotic syndrome. Representative examples of neoplastic conditions include benign processes (e.g., renal lipoma and renal fibroma) and malignant processes (e.g., renal cell carcinoma and renal lymphoma).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7C084539-0EDE-6AD0-E040-BB89AD43189B","latestVersionIndicator":"Yes","beginDate":"2009-12-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2009-12-31","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"052E2F8B-062B-5A45-E063-731AD00A8154","beginDate":"2023-09-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-12","modifiedBy":"COLBERTM","dateModified":"2023-09-12","deletedIndicator":"No"},{"value":"End-stage Renal Disease","valueDescription":null,"ValueMeaning":{"publicId":"4395774","version":"1","preferredName":"Chronic Kidney Disease, Stage 5","longName":"4395774","preferredDefinition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Kidney Disease, Stage 5","conceptCode":"C9439","definition":"Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB8F754-D9B5-8D06-E040-BB89AD437F49","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"COOPERM","dateModified":"2019-03-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"052E2F8B-062C-5A45-E063-731AD00A8154","beginDate":"2023-09-12","endDate":null,"createdBy":"COLBERTM","dateCreated":"2023-09-12","modifiedBy":"COLBERTM","dateModified":"2023-09-12","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4783271","version":"1","preferredName":"Cause of Death Reason","preferredDefinition":"The circumstance or condition that results in the death of a living being.:An explanation of the cause of some phenomenon or action.","longName":"C81239:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cause of Death","conceptCode":"C81239","definition":"The circumstance or condition that results in the death of a living being.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"132D4785-52BC-5337-E050-BB89AD433CA8","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"ONEDATA","dateModified":"2015-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"132D4785-52CD-5337-E050-BB89AD433CA8","latestVersionIndicator":"Yes","beginDate":"2015-04-07","endDate":null,"createdBy":"CHILLIJ","dateCreated":"2015-04-07","modifiedBy":"COLBERTM","dateModified":"2023-09-12","changeDescription":"7/19/17 jk transferred context and added registration status, CSI per Round 5 finalization task. 5/11/16 Added \"Drug related\" for OSHU. jk 5/4/16 Added \"Adverse event\" and \"Unknown\" for OSHU. jk 4/28/15 Released; Infection added for COG AAML1331 Death CRF. jc 4/16/15 Thrombosis added for COG AAML1331 Death CRF. jc  4/7/15 Harmonized long list of COD reasons as determined by COD Harmonization WG efforts. jc","administrativeNotes":"4/12/23 added 2 PVs for the PCDC-C3DC Aggregated Dictionary data elements. jk","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6921971","version":"1","longName":"CDISC Aligned Collection CDEs","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"7318690","version":"1","longName":"Survival and Follow-Up - CDISC Aligned","context":"NCI Standards"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Contributing cause","type":"Preferred Question Text","description":"Contributing cause","url":null,"context":"NCI Standards"},{"name":"CDISC Aligned NCI Standard Equivalent CDE","type":"CDISC Note","description":"This data element is to be used for CDISC aligned data collection in place of CDE 4783291 from the original NCI Standard CRF Template.","url":null,"context":"NCI Standards"}],"origin":"NCI CRF Standards","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"9743D43D-44C5-4A77-E053-F662850A284E","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-11-13","modifiedBy":"GDEEN","dateModified":"2023-02-13","changeDescription":"Released. AK 2020-6-17; Created for CDSIC aligned NCI Standard CRFs. ghd","administrativeNotes":"02.13.23_Set Reg Status to Standard for all CDISC Aligned content_ghd","unresolvedIssues":null,"deletedIndicator":"No"}}